Header Logo

Connection

THOMAS KOSTEN to Depressive Disorder, Treatment-Resistant

Back to Details
This is a "connection" page, showing publications THOMAS KOSTEN has written about Depressive Disorder, Treatment-Resistant.
THOMAS KOSTEN
Connection Strength
0.046
Depressive Disorder, Treatment-Resistant
  1. Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial. J Clin Psychiatry. 2024 Jun 17; 85(3).
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.